LY96
LY96geneLY96 amplifies TLR-mediated monocyte and endothelial activation, intensifying plaque inflammation and atherothrombotic susceptibility.
Pathway placement
Cascade stepPlaque inflammation
Confidencehigh
RationaleLymphocyte antigen 96; co-receptor for TLR4 and TLR2, essential for lipopolysaccharide and pathogen sensing.
Druggability
DruggableYes
Known drugs / candidates2
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000154589
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(1)
- Identification of core genes shared by ischemic stroke and myocardial infarction using an integrated approach.Medicine · 2024 · PMID 38968466 · doi